A community pharmacist spends a large proportion of their working day responding to symptoms and counselling patients on minor ailments such as eye health.
The aim of this course is to provide an an overview of the most common conditions that affect the human eye and to provide practice points on the management of these conditions.
A biosimilar is a biological medicine that is highly similar to another already authorised biological medicine. Increased numbers of biosimilars are likely to become available in Ireland in the coming years and will be used for treatment of a variety of conditions including inflammatory bowel disease, arthritis, and cancer treatment.
The aim of this course is to provide an overview of the production, licencing and current use of biosimilars in Ireland.
Arthritis is an inflammation of the joints that causes pain and immobility, ranging from mild to severe. In Ireland around 915,000 people, including 1 in every 1,200 children, are living with arthritis, making it the single biggest cause of disability.
The aim of this course is to provide an overview of the most common types of arthritis, treatments available and useful support and self-help options.
There are currently over 55,000 people living with dementia in Ireland, according to and this number is projected to increase to 113,000 by 2036. The community pharmacist is ideally placed to provide information on drug treatment and signpost information and support resources to patients and their carers.
The aim of this course is to describe the different types of dementia, their development and diagnosis as well as reviewing drug treatment and signposting patient information and support services.
The licenced indications, prescribing volume and course duration for opioid analgesics has increased steadily in recent years, alongside an upsurge in new opioid analgesics being brought to market.
The aim of this course is to provide an update on the use of opioid analgesics in chronic pain management and to advise on how to minimise and manage the clinical risks to patients.
It is widely acknowledged that cholesterol is a significant modifiable risk factor for coronary heart disease (CHD). However, despite the wealth of evidence on the benefit of cholesterol reduction in reducing the risk of a cardiovascular event, many patients are still unaware of this positive impact and thus the importance of risk factor screening.
The aim of this course is to provide an update on the impact of cholesterol as a CHD risk factor, target values for lipids and effective management strategies to achieve and maintain optimal cholesterol values.
Atrial Fibrillation (AF) is a cardiac arrhythmia which, if not managed correctly, places patients at an increased risk of stroke. With our aging population, the incidence of AF is growing, which gives rise to an increased emphasis on the understanding, screening and treatment of AF.
The aim of this course is to provide an overview of AF risk factors, outline treatment options available and provide useful information on AF monitoring and management.
Proton Pump Inhibitors (PPIs) continue to be the most widely prescribed items in Ireland (PCRS, 2015). The IPU Academy Spring Programme 2013 course on PPIs discussed the indication for their use, as well as highlighting emerging concerns around the long-term use of PPIs.
The aim of this course is to provide an update on the safety and efficacy of PPIs and provide information on auditing use of PPIs in at-risk patient groups such as the elderly or nursing home residents.
Cystic Fibrosis (CF) is Ireland's most common genetically inherited disease. With over 1,200 patients with Cystic Fibrosis, Ireland has the highest incidence (per head of population) of CF in the world.
The aim of this course is to provide an overview of CF, its causes, symptoms and all options available for its treatment and management.
Thyroid dysfunction can manifest itself in many ways so the diagnosis of a thyroid disorder may be delayed because of the range of symptoms linked to thyroid disorders.
The aim of this course to provide information on the symptoms, diagnostic criteria and management of thyroid disorders.